3AVIVA E, GERSHAN G. Administration routes and delivery system of bisphosphonates for the treatment of bone resorption[J].Adv Drug Deliv Rev, 2000, 42:175-195. 被引量：1
4AGNIHOTRI S A, MALLIKARJUNA N N, AMINABHAVI T M. Recent advances on chitosan-based micro- and nanoparticles in dug delivery[J]. J Control Release, 2004, 100: 5-28. 被引量：1
5PRABAHARAN M,MANO J F. Chitosan-based particles as controlled drug delivery system[J]. Drug Deliv, 2005, 12:41-57. 被引量：1
6SINHA V R, SINGLA A K, WADHAWAN S, et al. Chitosan naicrospheres as a potential carrier for drugs[J]. Int J Pharm, 2004, 274:1-33. 被引量：1
7PATASHNIK S, RABINOVICH L, GOLOMB G. Preparation and evaluation of ehitosan rnicrospheres containing bisphosphonates[J].J Drug Target, 1997, 4: 371-380. 被引量：1
8HIRABAYASHI H, FUJISAKI J. Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents[J]. Clin Pharmacokinet, 2003, 42(15): 1319-1330. 被引量：1
10FUJISAKI J, TOKUNAGA Y, TAKAHASHI T, et al, Osteotropic drug delivery system(ODDS)based on bisphosphonic prodrug.Ⅰ. synthesis and in vivo characterization of osteotropic carboxy-fluorescein[J]. J Drug Target, 1995, 3: 273-282. 被引量：1
